Search hospitals > California > Concord
John Muir Medical Center-Concord Campus
Claim this profileConcord, California 94520
Global Leader in Skin Cancer
Global Leader in Relapse
Conducts research for Ovarian Cancer
Conducts research for Stomach Cancer
Conducts research for Breast Cancer
140 reported clinical trials
4 medical researchers
Summary
John Muir Medical Center-Concord Campus is a medical facility located in Concord, California. This center is recognized for care of Skin Cancer, Relapse, Ovarian Cancer, Stomach Cancer, Breast Cancer and other specialties. John Muir Medical Center-Concord Campus is involved with conducting 140 clinical trials across 200 conditions. There are 4 research doctors associated with this hospital, such as Babak Edraki, MD, Gigi Q. Chen, Tiffany H. Svahn, and Wilson Tsai, MD.Area of expertise
1Skin Cancer
Global LeaderStage II
HER2 positive
Stage I
2Relapse
Global LeaderStage III
Stage IV
BRCA1 positive
Top PIs
Babak Edraki, MDJohn Muir Medical Center-Concord Campus2 years of reported clinical research
Studies Thyroid Cancer
Studies Fallopian Tube Cancer
8 reported clinical trials
25 drugs studied
Gigi Q. ChenJohn Muir Medical Center-Concord Campus3 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
6 reported clinical trials
14 drugs studied
Tiffany H. SvahnJohn Muir Medical Center-Walnut Creek5 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
7 drugs studied
Wilson Tsai, MDJohn Muir Health3 years of reported clinical research
Studies Lung Cancer
1 reported clinical trial
1 drug studied
Clinical Trials running at John Muir Medical Center-Concord Campus
Breast Cancer
Heart Failure
Lung Cancer
Uterine Cancer
Skin Cancer
Non-Small Cell Lung Cancer
Breast cancer
Cardio-Renal Syndrome
Endometrial Adenocarcinoma
Squamous Cell Carcinoma
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at John Muir Medical Center-Concord Campus?
John Muir Medical Center-Concord Campus is a medical facility located in Concord, California. This center is recognized for care of Skin Cancer, Relapse, Ovarian Cancer, Stomach Cancer, Breast Cancer and other specialties. John Muir Medical Center-Concord Campus is involved with conducting 140 clinical trials across 200 conditions. There are 4 research doctors associated with this hospital, such as Babak Edraki, MD, Gigi Q. Chen, Tiffany H. Svahn, and Wilson Tsai, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.